NasdaqGM:HRMYPharmaceuticals
Did CFO Exit and Reaffirmed 2026 Guidance Just Shift Harmony Biosciences' (HRMY) Investment Narrative?
Harmony Biosciences Holdings, Inc. recently announced that Chief Financial Officer Glenn Reicin stepped down on July 16, 2026, with Senior Vice President and Controller Stephen Mollichella appointed as Interim Principal Financial Officer while the company searches for a permanent successor.
At the same time, Harmony reaffirmed its full-year 2026 net product revenue guidance of between US$1.00 billion and US$1.04 billion, signaling confidence in its operations despite the leadership...